Revised outcome of circular resolution passed by the Board of directors on 31st March, 2026 for allotment of 29,703 Warrants convertible into Equity shares on preferential basis.
FUNDRAISE
● No Immediate Change
MEDIUM RISK
📅 Filed on BSE: 03 Apr 2026, 07:14 PM IST · BSE ID: 86d0c9e0-17c4-4b91-94d9-62720a435516
View Original BSE Filing (PDF)
💡
In Simple Terms
Suditi issued 29,703 convertible warrants to one investor, who paid part upfront and owes the balance within 18 months to convert into equity shares.
🤖 AI Summary
- Board allotted 29,703 convertible warrants at Rs. 59.12 per warrant, total Rs. 17,56,041.36
- Single non-promoter allottee: Nitu Ashish Bansal; upfront subscription received Rs. 4,39,010.34
- Warrant subscription price Rs. 14.78 per warrant (25%); exercise price Rs. 44.34 (75%)
- Conversion into equity shares of face value Rs. 10 within 18 months from allotment
- Locked-in period applies under SEBI ICDR Regulations 2018; no capital change at allotment
🔢 Key Numbers — exact figures from BSE filing, not rounded
Warrants allotted
29,703 units
Total warrant issue price
Rs. 17,56,041.36
Price per warrant
Rs. 59.12
Upfront subscription received
Rs. 4,39,010.34
Warrant subscription price (25%)
Rs. 14.78 per warrant
Warrant exercise price (75%)
Rs. 44.34 per warrant
Conversion tenure
18 months from allotment
Equity share face value
Rs. 10 per share
Number of allottees
1 (non-promoter)
🏢 How This Affects the Company
Company received Rs. 4,39,010.34 upfront warrant subscription. Deferred cash of Rs. 13,16,945.02 conditional on warrant exercise within 18 months. No immediate capital or earnings impact; full capital recognition depends on conversion execution.
Warrant conversion is optional and subject to 18-month tenure. If not exercised, no additional capital flows. Single allottee concentration in this tranche creates execution risk on deferred cash realization.
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor warrant exercise status in 18-month period via shareholder updates and quarterly disclosures.
👤
Who Is Affected
All existing equity shareholders. Potential dilution of 29,703 shares (0.31% of current equity) if warrants exercised. Impact on EPS and shareholding % depends on conversion timing and company capital raises during tenure.
🔍
Management Signal
Company pursuing preferential capital raise from identified institutional investors. Single allottee structure suggests targeted strategic capital, not broad market placement.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Warrant exercise status at 6-month mark — track partial or full conversion filings
FY27 shareholding pattern disclosure — verify dilution impact if warrants converted
18-month expiry date tracking — confirm exercise/lapse outcome in final announcement
MEDIUM RISK
Single allottee concentration and optional warrant exercise create contingency risk on deferred capital realization. Non-exercise leaves 75% of capital unrecovered.
💡 Investor Takeaway
Suditi allotted 29,703 warrants at Rs. 59.12 each (total Rs. 17,56,041.36) to one non-promoter. Upfront cash of Rs. 4,39,010.34 received. Remaining Rs. 13,16,945.02 due on conversion within 18 months. Conversion is optional; actual equity dilution and capital accretion contingent on exercise.
⚖️ Strengths & Concerns
✅ Positives
- Upfront capital received of Rs. 4,39,010.34 improves immediate cash position and commitment signal
- 18-month exercise window provides flexibility for allottee while securing deferred capital for company
⚠️ Concerns
- Single allottee concentration in warrant tranche increases execution risk on deferred cash realization
- Deferred capital of Rs. 13,16,945.02 (75% of total) is contingent on voluntary warrant exercise
📅 Company Track Record
Suditi Industries conducted multiple preferential allotments in March–April 2026. On 31 March 2026, the company allotted 5,39,800 equity shares and 25.05 lakh convertible warrants raising Rs. 19.67 Crore total from 8 non-promoter investors, diluting equity by 20.08 lakh shares. This 29,703-warrant allotment appears as a separate tranche from the same circular resolution date, targeting a single strategic investor.
Based on publicly available historical data. For context only.